{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:21:42Z","timestamp":1785910902255,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AG024904"],"award-info":[{"award-number":["U19 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tjpad.2025.100445","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T20:14:14Z","timestamp":1763928854000},"page":"100445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance"],"prefix":"10.1016","volume":"13","author":[{"given":"Alison","family":"Myoraku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Hausle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-4597","authenticated-orcid":false,"given":"Marta","family":"Mila-Aloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5371-8667","authenticated-orcid":false,"given":"Pamela","family":"Thropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7164-2148","authenticated-orcid":false,"given":"Laura A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-7724","authenticated-orcid":false,"given":"Duygu","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100445_bib0001","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-220959","article-title":"Exploring reasons for differential vulnerability and Alzheimer\u2019s Disease risk in racial and ethnic minorities","volume":"91","author":"Daniel","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100445_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1107372","article-title":"Health disparities in aging: improving dementia care for black women","volume":"15","author":"Findley","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.tjpad.2025.100445_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7559","article-title":"Association of neighborhood-level Disadvantage with Alzheimer Disease neuropathology","volume":"3","author":"Powell","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tjpad.2025.100445_bib0004","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/jgs.15258","article-title":"Effect of area-level socioeconomic deprivation on risk of cognitive dysfunction in older adults","volume":"66","author":"McCann","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.tjpad.2025.100445_bib0005","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/alz.12702","article-title":"Association of neighborhood socioeconomic disadvantage and cognitive impairment","volume":"19","author":"Vassilaki","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0006","article-title":"The Area Deprivation Index: a novel tool for harmonizable risk assessment in Alzheimer\u2019s disease research","volume":"6","author":"Zuelsdorff","year":"2020","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"10.1016\/j.tjpad.2025.100445_bib0007","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible \u2014 The neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100445_bib0008","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaneurol.2023.2120","article-title":"Dementia risk and disadvantaged neighborhoods","volume":"80","author":"Dintica","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70095","article-title":"Association of neighborhood disadvantage with cognitive function and cortical disorganization in an unimpaired cohort: an exploratory study","volume":"21","author":"Safai","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14257","article-title":"Differential associations of neighborhood disadvantage, race\/ethnicity, and cognitive status with experiences of psychosocial distress in the HABS-HD cohort","volume":"21","author":"Rhoads","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289893","article-title":"South Asian, Black and White ethnicity and the effect of potentially modifiable risk factors for dementia: a study in english electronic health records","volume":"18","author":"Mukadam","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.tjpad.2025.100445_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.930415","article-title":"Area deprivation index as a surrogate of resilience in aging and dementia","volume":"13","author":"Vassilaki","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mayocp.2021.09.006","article-title":"Associations of neighborhood socioeconomic disadvantage with chronic conditions by age, sex, race, and ethnicity in a population-based cohort","volume":"97","author":"Chamberlain","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tjpad.2025.100445_bib0014","article-title":"Differences in the potential for dementia prevention between major ethnic groups within one country: a cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand","volume":"13","author":"Ma\u2019u","year":"2021","journal-title":"Lancet Reg Health - West Pac"},{"key":"10.1016\/j.tjpad.2025.100445_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","article-title":"Inequalities in dementia incidence between six racial and ethnic groups over 14 years","volume":"12","author":"Mayeda","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14283\/jarlife.2024.1","article-title":"Association between modifiable risk factors and levels of blood-based biomarkers of Alzheimer\u2019s and related dementias in the look AHEAD cohort","volume":"13","author":"Hayden","year":"2024","journal-title":"J Aging Res Lifestyle"},{"key":"10.1016\/j.tjpad.2025.100445_bib0017","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207675","article-title":"Association of plasma biomarkers of Alzheimer disease with cognition and medical comorbidities in a biracial cohort","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100445_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/alz.051948","article-title":"Longitudinal associations between racial discrimination and brain aging among black older adults","volume":"17","author":"Zahodne","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0019","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaneurol.2022.0976","article-title":"Risk factors associated with Alzheimer Disease and related dementias by sex and race and ethnicity in the US","volume":"79","author":"Nianogo","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3233\/ADR-230155","article-title":"Social determinants of health, risk and resilience against Alzheimer\u2019s disease and related dementias: the Healthy Brain Initiative","volume":"8","author":"Besser","year":"2024","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.tjpad.2025.100445_bib0021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.25948","article-title":"Socioeconomic status mediates racial differences seen using the AT(N) framework","volume":"89","author":"Meeker","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamaneurol.2019.4501","article-title":"Association of neighborhood-level disadvantage with cerebral and hippocampal volume","volume":"77","author":"Hunt","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0023","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/alz.13736","article-title":"Neighborhood disadvantage reduces cognitive reserve independent of neuropathologic change","volume":"20","author":"Kim","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0024","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-Head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0025","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100445_bib0026","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100445_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100445_bib0028","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tjpad.2025.100445_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105805","article-title":"Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis","volume":"117","author":"Lehmann","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.tjpad.2025.100445_bib0030","article-title":"Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0031","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma a\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100445_bib0032","unstructured":"FDA clears first blood test used in diagnosing Alzheimer\u2019s disease. US food drug adm 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease (accessed September 22, 2025)."},{"key":"10.1016\/j.tjpad.2025.100445_bib0033","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0034","article-title":"Neurofilament light chain levels in serum among a large mixed memory clinic cohort: confounders and diagnostic usefulness","volume":"15","author":"Simonsen","year":"2023","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"10.1016\/j.tjpad.2025.100445_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/alz.12647","article-title":"for the HABS-HD Study Team. Medical comorbidities and ethnicity impact plasma Alzheimer\u2019s disease biomarkers: important considerations for clinical trials and practice","volume":"19","author":"O\u2019Bryant","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0036","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200358","article-title":"Effect of race on prediction of brain amyloidosis by plasma A\u03b242\/A\u03b240, phosphorylated tau, and neurofilament light","volume":"99","author":"Schindler","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100445_bib0037","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0038","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100445_bib0039","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease neuroimaging initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100445_bib0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/M13-2946","article-title":"Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study","volume":"161","author":"Kind","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tjpad.2025.100445_bib0041","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14378","article-title":"Positron emission tomography harmonization in the Alzheimer\u2019s Disease Neuroimaging Initiative: a scalable and rigorous approach to multisite amyloid and tau quantification","volume":"21","author":"Landau","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0043","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100445_bib0044","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yfrne.2014.01.002","article-title":"Sex differences in cognitive impairment and Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2014","journal-title":"Front Neuroendocr"},{"key":"10.1016\/j.tjpad.2025.100445_bib0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2025.100445_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2025.100717","article-title":"Factors related to blood-based biomarkers for neurodegenerative diseases and their intergenerational associations in the Young Finns Study: a cohort study","volume":"6","author":"Heiskanen","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.tjpad.2025.100445_bib0047","article-title":"Effects of vascular risk factors on the association of blood-based biomarkers with Alzheimer\u2019s disease","volume":"11","author":"Hoost","year":"2023","journal-title":"Med Res Arch"},{"key":"10.1016\/j.tjpad.2025.100445_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70426","article-title":"Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort","volume":"21","author":"Rudolph","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0049","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100445_bib0050","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011599","article-title":"Amyloid PET imaging in self-identified Non-Hispanic black participants of the Anti-Amyloid in asymptomatic Alzheimer\u2019s Disease (A4) study","volume":"96","author":"Deters","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100445_bib0051","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2022.3157","article-title":"Racial and ethnic differences in amyloid PET positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the imaging dementia\u2013Evidence for amyloid scanning (IDEAS) cohort study","volume":"79","author":"Wilkins","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0052","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0053","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.tjpad.2025.100445_bib0054","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2022.09.006","article-title":"Plasma amyloid-\u03b2 in relation to cardiac function and risk of heart failure in general population","volume":"11","author":"Zhu","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.tjpad.2025.100445_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaneurol.2023.4719","article-title":"Effect of neprilysin inhibition on Alzheimer Disease plasma biomarkers: a secondary analysis of a randomized clinical trial","volume":"81","author":"Brum","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100445_bib0056","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bcp.12861","article-title":"The effect of LCZ696 (sacubitril\/valsartan) on amyloid-\u03b2 concentrations in cerebrospinal fluid in healthy subjects","volume":"81","author":"Langenickel","year":"2016","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:25:03Z","timestamp":1776198303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2274580725003863"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100445","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100445"}}